Ablation in HFpEF; Better BP Threshold for Women; Vascular Closure Device Risk

Atrial fibrillation ablation looked better than drug therapy among patients with stable heart failure, largely with preserved ejection fraction, in the CABANA trial. (Circulation)

The systolic blood pressure threshold for cardiovascular disease risk was 110 mm Hg for women, compared with 120 mm Hg in men in large cohort studies. (Circulation)

A look at the MAUDE database turned up major complications and deaths from suture-based vascular closure devices. (Catheterization & Cardiovascular Interventions)

COVID-19 first-dose vaccination appeared safe for solid organ transplant patients, without any rejection episodes in early follow-up. (Transplantation)

Heart failure cases nearly doubled globally since 1990. (European Journal of Preventive Cardiology)

Heart disease deaths are rising in young and middle-aged women. (European Heart Journal – Quality of Care & Clinical Outcomes)

A federal appeals court may have closed the patent fights over PCSK9 inhibitors, ruling that Amgen can’t patent the class. (Endpoints News)

A judge in Hawaii ordered Bristol Myers Squibb and Sanofi to pay $834 million for knowing that clopidogrel (Plavix) is less effective in non-white populations but failing to disclose it on the label until required by the FDA in 2010. (Reuters)

Vascular surgeons say they’re undervalued. (Journal of Vascular Surgery)

Adults with congenital heart disease are more likely to have heart failure and stroke. (Morbidity and Mortality Weekly Report)

Collaborative team care improved hypertension and diabetes in primary care. (JAMA Network Open)

FDA approved Shockwave Medical’s intravascular lithotripsy device for severely calcified coronary artery disease. (Cardiovascular Business)

The agency cleared B-Secur’s HeartKey software library for arrhythmia detection. (Medical Design & Outsourcing)

Google is adding heart and respiratory rate monitors to its Pixel phones using only the camera. (The Verge)

Polynesian ancestry was linked to heart failure and cardiometabolic risk among Native Hawaiians. (PLOS Genetics)

Another study suggested greater hypertensive and other health risks from obesity for Chinese people than for other racial and ethnic groups. (Journal of Clinical Endocrinology & Metabolism)